Medicine and Dentistry
Patient
100%
COVID-19
40%
Inpatient
31%
Analysis
27%
Hospital
23%
Ventilator-Associated Pneumonia
20%
Mortality
16%
Therapeutic Procedure
15%
Culture
14%
Breathing
13%
Pneumonia
13%
Antiinfective Agent
13%
Volatile Organic Compound
12%
Evaluation Study
12%
Adult
11%
Anti-biotics
10%
Systematic Review
10%
Organ
9%
Blood
8%
Pathogen
8%
Asthma
7%
Lung
7%
Biological Marker
7%
Life
6%
Diagnostics
6%
Intensive Care Unit
6%
Aspergillus
6%
Aminoglycoside
6%
Beta Lactam
6%
Colistin
6%
T Cell
6%
Tracheobronchial Toilet
6%
Pathogenesis
6%
Intensive Care
6%
Carbapenem-Resistant Enterobacteriaceae
5%
Pleurodesis
5%
Pneumothorax
5%
Pediatrics
5%
Fibrin
5%
COVID-19 Therapy
5%
Multidrug-Resistant Gram-Negative Bacteria
5%
Von Willebrand Factor Cleaving Proteinase
5%
Coagulopathy
5%
Childhood
5%
B Cell
5%
Comprehension
5%
Diagnostic Test
5%
Fibrinolysis
5%
Cell Function
5%
Extracorporeal Membrane Oxygenation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
40%
Infection
30%
Pharmacodynamics
28%
Ventilator Associated Pneumonia
23%
Antiinfective Agent
22%
Mortality
14%
Pneumonia
14%
Piperacillin
12%
Meningoencephalitis
11%
Antibiotics
10%
Antibiotic Agent
9%
Aminoglycoside
9%
Coronavirinae
9%
Infectious Agent
9%
Diseases
8%
Drug
8%
Candida
8%
Incidence
7%
Volatile Organic Compound
7%
Clinical Trial
7%
Antifungal
7%
Antimicrobial Resistance
7%
Triazole
6%
Colistin
6%
Bloodstream Infection
6%
Antifungal Therapy
6%
Respiratory Tract Infection
6%
Posaconazole
6%
Invasive Aspergillosis
6%
Beta Lactam
6%
Aspergillus
6%
Tazobactam
6%
Voriconazole
6%
Lung Aspergillosis
6%
Candidemia
5%
Therapeutic Drug Monitoring
5%
Isavuconazole
5%
Carbapenem Resistant Enterobacteriaceae
5%
Anidulafungin
5%
Amphotericin B
5%
Pseudomonas aeruginosa
5%
Multidrug-Resistant Gram-Negative Bacteria
5%
Enterobacteriaceae Infection
5%
Adverse Event
5%
Piperacillin Plus Tazobactam
5%
Human
5%
Antifungal Agent
5%
Nursing and Health Professions
Patient
13%
Diseases
11%
Intensive Care
11%
Hospital
10%
Evaluation Study
7%
Mortality
7%
Ventilator-Associated Pneumonia
6%
Analysis
6%
Antiinfective Agent
6%
Extracorporeal Oxygenation
5%
Adult
5%
Time
5%